<?xml version="1.0" encoding="UTF-8"?>
<p>End points in this study were evaluated according to the IWCLL criteria
 <sup>
  <xref rid="b28-1040797" ref-type="bibr">28</xref>
 </sup> and included: ORR, duration of response (DOR), PFS, OS and safety. In the analysis of PFS, time was calculated from the start date of first-line therapy to the date of progression or date of death, whichever came first. In the analysis of OS, time was calculated from the date of first-line therapy to the date of death. For event-free patients, time was calculated to the date of last clinical visit.
</p>
